RARE - Ultragenyx Pharmaceutical Inc.
21.8
-0.270 -1.239%
Share volume: 2,251,986
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$22.07
-0.27
-0.01%
Summary score
8%
Profitability
0%
Dept financing
10%
Liquidity
75%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-12.44%
Return on assets
-11.81%
Return on sales
-746.4%
Return on invested capital
-54.35%
Total debt ratio
22.44%
Debt ratio change over timeo
0%
Current Ratio
7.23%
Quick Ratio
7.22%
Cash Position Ratio
2.09%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-10.15%
Return on assets
-6.7%
Return on sales
-190.41%
Return on invested capital
-38.83%
Total debt ratio
46.99%
Debt ratio change over timeo
0%
Current Ratio
5.31%
Quick Ratio
5.24%
Cash Position Ratio
2.06%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-10.33%
Return on assets
-3.97%
Return on sales
-61.76%
Return on invested capital
-35.27%
Total debt ratio
47.48%
Debt ratio change over time
0%
Current Ratio
4.33%
Quick Ratio
4.26%
Cash Position Ratio
0.99%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RARE | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -12.44% | 18.71% | 4.67% | -3.65% |
| Return on assets | -11.81% | 3.4% | 3.32% | 3.5% |
| Return on sales | -746.4% | 24.27% | 25.81% | 31.31% |
| Return on invested capital | -54.35% | 5.38% | 4.17% | 4.99% |
| Profitability | 0% | 94% | 70% | 73% |
| Total debt ratio | 22.44% | 78.91% | 58.54% | 101.15% |
| Debt ratio change over time | 0% | 0% | 10.69% | 52.18% |
| Dept financing | 6% | 20% | 20% | 50% |
| Current Ratio | 5.31% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 5.24% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 2.06% | 0.21% | 0.6% | 1.41% |
| Liquididy | 75% | 12% | 17% | 18% |
| Short-term ratios | RARE | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -10.15% | 41.05% | 6.87% | -16.17% |
| Return on assets | -6.7% | 3.67% | 3.13% | 2.71% |
| Return on sales | -190.41% | 26.16% | 24.75% | 29.9% |
| Return on invested capital | -38.83% | 9.43% | 5.58% | 6.54% |
| Profitability | 0% | 97% | 61% | 61% |
| Total debt ratio | 46.99% | 91.28% | 61.3% | 99.31% |
| Debt ratio change over time | 0% | 0% | 13.89% | -24.55% |
| Dept financing | 12% | 23% | 40% | 25% |
| Current Ratio | 5.31% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 5.24% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 2.06% | 0.21% | 0.6% | 1.41% |
| Liquididy | 75% | 13% | 19% | 36% |